The REal Life EVidence AssessmeNt Tool (RELEVANT): development of a novel quality assurance asset to rate observational comparative effectiveness research studies
Abstract Background Evidence from observational comparative effectiveness research (CER) is ranked below that from randomized controlled trials in traditional evidence hierarchies. However, asthma observational CER studies represent an important complementary evidence source answering different rese...
Main Authors: | Jonathan D. Campbell, Robert Perry, Nikolaos G. Papadopoulos, Jerry Krishnan, Guy Brusselle, Alison Chisholm, Leif Bjermer, Michael Thomas, Eric van Ganse, Maarten van den Berge, Jennifer Quint, David Price, Nicolas Roche |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-03-01
|
Series: | Clinical and Translational Allergy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13601-019-0256-9 |
Similar Items
-
Quality standards in respiratory real-life effectiveness research: the REal Life EVidence AssessmeNt Tool (RELEVANT): report from the Respiratory Effectiveness Group—European Academy of Allergy and Clinical Immunology Task Force
by: Nicolas Roche, et al.
Published: (2019-03-01) -
Alternative Process Routes to Manufacture Porous Ceramics—Opportunities and Challenges
by: Uwe Scheithauer, et al.
Published: (2019-02-01) -
An assessmant of the IT governance maturity at SL
by: Castillo, Felipe
Published: (2011) -
Long noncoding RNA CERS6‐AS1 functions as a malignancy promoter in breast cancer by binding to IGF2BP3 to enhance the stability of CERS6 mRNA
by: Gang Bao, et al.
Published: (2020-01-01) -
Shiga toxin glycosphingolipid receptors in microvascular and macrovascular endothelial cells: differential association with membrane lipid raft microdomains[S]
by: Josefine Betz, et al.
Published: (2011-04-01)